Italy In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others.

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

GlobalData’s “Italy In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Italy In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health.

The Italy In Vitro Diagnostics Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for In Vitro Diagnostics Market.
• Global corporate-level profiles of key companies operating within the Italy In Vitro Diagnostics Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Italy In Vitro Diagnostics Tests is segmented as follows:

• Cardiac Disease

• Clinical Chemistry

• Hematological Disorders

• Hormonal Disorder

• Infectious Disease

• IVD Analyzers and Reagents

• Metabolic Disorder

• Oncology

• Women's Health

Reasons to Buy

Key Reasons to Purchase – The Italy In Vitro Diagnostics Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “Italy In Vitro Diagnostics Market Outlook to 2025” report:
• F. Hoffmann-La Roche Ltd
• Siemens Healthineers AG
• Abbott Laboratories

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 9

2 Introduction 12

2.1 What Is This Report About? 12

2.2 In Vitro Diagnostics Market Segmentation 12

2.3 Definitions of Markets Covered in the Report 16

3 In Vitro Diagnostics Market, Italy 42

3.1 In Vitro Diagnostics Market, Italy, Revenue ($m), 2015-2025 42

3.2 In Vitro Diagnostics Market, Italy, Revenue Mix ($m), 2018 44

3.3 In Vitro Diagnostics Market, Italy, Category Contribution by Revenue ($m), 2018 45

3.4 In Vitro Diagnostics Market, Italy, Revenue ($m), 2015-2025 47

3.5 In Vitro Diagnostics Market, Italy, Volume (Units), 2015-2025 50

3.6 In Vitro Diagnostics Market, Italy, Volume (Units), 2015-2025 52

3.7 In Vitro Diagnostics Market, Italy, Company Share by Revenue ($m), 2018 55

4 Cardiac Disease Market, Italy 57

4.1 Cardiac Disease Market, Italy, Revenue ($m), 2015-2025 57

4.1.1 Cardiac Marker Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 59

4.2 Cardiac Disease Market, Italy, Volume (Units), 2015-2025 62

4.2.1 Cardiac Marker Tests Market, Italy, Volume (Units), by Segment, 2015-2025 64

4.3 Cardiac Disease Market, Italy, Average Price ($), 2015-2025 67

4.4 Cardiac Disease Market, Italy, Distribution Share by Revenue ($m), 2018 69

4.5 Cardiac Disease Market, Italy, Company Share by Revenue ($m), 2018 70

5 Clinical Chemistry Market, Italy 72

5.1 Clinical Chemistry Market, Italy, Revenue ($m), 2015-2025 72

5.1.1 Substrates Market, Italy, Revenue ($m), by Segment, 2015-2025 74

5.2 Clinical Chemistry Market, Italy, Volume (Units), 2015-2025 77

5.2.1 Substrates Market, Italy, Volume (Units), by Segment, 2015-2025 79

5.3 Clinical Chemistry Market, Italy, Average Price ($), 2015-2025 82

5.4 Clinical Chemistry Market, Italy, Distribution Share by Revenue ($m), 2018 84

5.5 Clinical Chemistry Market, Italy, Company Share by Revenue ($m), 2018 85

6 Hematological Disorders Market, Italy 86

6.1 Hematological Disorders Market, Italy, Revenue Mix ($m), 2018 86

6.2 Hematological Disorders Market, Italy, Segment Contribution (%), 2018 87

6.3 Hematological Disorders Market, Italy, Revenue ($m), 2015-2025 88

6.3.1 Hematology Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 90

6.3.2 Hemostasis Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 93

6.4 Hematological Disorders Market, Italy, Volume (Units), 2015-2025 96

6.4.1 Hematology Tests Market, Italy, Volume (Units), by Segment, 2015-2025 98

6.4.2 Hemostasis Tests Market, Italy, Volume (Units), by Segment, 2015-2025 101

6.5 Hematological Disorders Market, Italy, Average Price ($), 2015-2025 104

6.6 Hematological Disorders Market, Italy, Distribution Share by Revenue ($m), 2018 108

6.7 Hematological Disorders Market, Italy, Company Share by Revenue ($m), 2018 109

7 Hormonal Disorders Market, Italy 111

7.1 Hormonal Disorders Market, Italy, Revenue ($m), 2015-2025 111

7.1.1 Thyroid Function Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 113

7.2 Hormonal Disorders Market, Italy, Volume (Units), 2015-2025 116

7.2.1 Thyroid Function Tests Market, Italy, Volume (Units), by Segment, 2015-2025 118

7.3 Hormonal Disorders Market, Italy, Average Price ($), 2015-2025 121

7.4 Hormonal Disorders Market, Italy, Distribution Share by Revenue ($m), 2018 123

7.5 Hormonal Disorders Market, Italy, Company Share by Revenue ($m), 2018 124

8 Infectious Disease Market, Italy 126

8.1 Infectious Disease Market, Italy, Revenue Mix ($m), 2018 126

8.2 Infectious Disease Market, Italy, Segment Contribution (%), 2018 127

8.3 Infectious Disease Market, Italy, Revenue ($m), 2015-2025 129

8.3.1 Chlamydia Trachomatis Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 132

8.3.2 Clostridium difficile Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 134

8.3.3 Cytomegalovirus (CMV) Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 137

8.3.4 Hepatitis Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 139

8.3.5 Human Immunodeficiency Virus (HIV) Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 141

8.3.6 Human Papilloma Virus (HPV) Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 144

8.3.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 146

8.3.8 Mycobacterium Tuberculosis Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 148

8.3.9 Neisseria Gonorrhoeae Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 150

8.3.10 Treponema pallidum Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 152

8.4 Infectious Disease Market, Italy, Volume (Units), 2015-2025 155

8.4.1 Chlamydia Trachomatis Tests Market, Italy, Volume (Units), by Segment, 2015-2025 160

8.4.2 Clostridium difficile Tests Market, Italy, Volume (Units), by Segment, 2015-2025 162

8.4.3 Cytomegalovirus (CMV) Tests Market, Italy, Volume (Units), by Segment, 2015-2025 165

8.4.4 Hepatitis Tests Market, Italy, Volume (Units), by Segment, 2015-2025 167

8.4.5 Human Immunodeficiency Virus (HIV) Tests Market, Italy, Volume (Units), by Segment, 2015-2025 169

8.4.6 Human Papilloma Virus (HPV) Tests Market, Italy, Volume (Units), by Segment, 2015-2025 172

8.4.7 Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Volume (Units), by Segment, 2015-2025 174

8.4.8 Mycobacterium Tuberculosis Tests Market, Italy, Volume (Units), by Segment, 2015-2025 176

8.4.9 Neisseria Gonorrhoeae Tests Market, Italy, Volume (Units), by Segment, 2015-2025 178

8.4.10 Treponema pallidum Tests Market, Italy, Volume (Units), by Segment, 2015-2025 180

8.5 Infectious Disease Market, Italy, Average Price ($), 2015-2025 183

8.6 Infectious Disease Market, Italy, Distribution Share by Revenue ($m), 2018 189

8.7 Infectious Disease Market, Italy, Company Share by Revenue ($m), 2018 190

9 IVD Analyzers and Reagents Market, Italy 192

9.1 IVD Analyzers and Reagents Market, Italy, Revenue Mix ($m), 2018 192

9.2 IVD Analyzers and Reagents Market, Italy, Segment Contribution (%), 2018 193

9.3 IVD Analyzers and Reagents Market, Italy, Revenue ($m), 2015-2025 194

9.3.1 Clinical Chemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2015-2025 197

9.3.2 Hematology Analyzers Market, Italy, Revenue ($m), by Segment, 2015-2025 199

9.3.3 Immunochemistry Analyzers Market, Italy, Revenue ($m), by Segment, 2015-2025 202

9.3.4 Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), by Segment, 2015-2025 205

9.4 IVD Analyzers and Reagents Market, Italy, Volume (Units), 2015-2025 208

9.4.1 Clinical Chemistry Analyzers Market, Italy, Volume (Units), by Segment, 2015-2025 211

9.4.2 Hematology Analyzers Market, Italy, Volume (Units), by Segment, 2015-2025 213

9.4.3 Immunochemistry Analyzers Market, Italy, Volume (Units), by Segment, 2015-2025 216

9.4.4 Polymerase Chain Reaction (PCR) Systems Market, Italy, Volume (Units), by Segment, 2015-2025 219

9.5 IVD Analyzers and Reagents Market, Italy, Average Price ($), 2015-2025 222

9.6 IVD Analyzers and Reagents Market, Italy, Distribution Share by Revenue ($m), 2018 226

9.7 IVD Analyzers and Reagents Market, Italy, Company Share by Revenue ($m), 2018 227

10 Metabolic Disorder Market, Italy 229

10.1 Metabolic Disorder Market, Italy, Revenue ($m), 2015-2025 229

10.1.1 Diabetes Assays Market, Italy, Revenue ($m), by Segment, 2015-2025 231

10.2 Metabolic Disorder Market, Italy, Volume (Units), 2015-2025 234

10.2.1 Diabetes Assays Market, Italy, Volume (Units), by Segment, 2015-2025 236

10.3 Metabolic Disorder Market, Italy, Average Price ($), 2015-2025 239

10.4 Metabolic Disorder Market, Italy, Distribution Share by Revenue ($m), 2018 241

10.5 Metabolic Disorder Market, Italy, Company Share by Revenue ($m), 2018 242

11 Oncology Market, Italy 244

11.1 Oncology Market, Italy, Revenue Mix ($m), 2018 244

11.2 Oncology Market, Italy, Segment Contribution (%), 2018 245

11.3 Oncology Market, Italy, Revenue ($m), 2015-2025 247

11.3.1 ALK Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 250

11.3.2 BRCA Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 252

11.3.3 Colorectal Cancer Screening Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 254

11.3.4 EGFR Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 256

11.3.5 HER2 Amplification Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 259

11.3.6 KRAS Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 261

11.4 Oncology Market, Italy, Volume (Units), 2015-2025 263

11.4.1 ALK Tests Market, Italy, Volume (Units), by Segment, 2015-2025 266

11.4.2 BRCA Tests Market, Italy, Volume (Units), by Segment, 2015-2025 268

11.4.3 Colorectal Cancer Screening Tests Market, Italy, Volume (Units), by Segment, 2015-2025 270

11.4.4 EGFR Tests Market, Italy, Volume (Units), by Segment, 2015-2025 272

11.4.5 HER2 Amplification Tests Market, Italy, Volume (Units), by Segment, 2015-2025 275

11.4.6 KRAS Tests Market, Italy, Volume (Units), by Segment, 2015-2025 277

11.5 Oncology Market, Italy, Average Price ($), 2015-2025 279

11.6 Oncology Market, Italy, Distribution Share by Revenue ($m), 2018 283

11.7 Oncology Market, Italy, Company Share by Revenue ($m), 2018 284

12 Women's Health Market, Italy 286

12.1 Women's Health Market, Italy, Revenue Mix ($m), 2018 286

12.2 Women's Health Market, Italy, Segment Contribution (%), 2018 287

12.3 Women's Health Market, Italy, Revenue ($m), 2015-2025 288

12.3.1 Prenatal Screening Market, Italy, Revenue ($m), by Segment, 2015-2025 290

12.3.2 Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), by Segment, 2015-2025 293

12.4 Women's Health Market, Italy, Volume (Units), 2015-2025 296

12.4.1 Prenatal Screening Market, Italy, Volume (Units), by Segment, 2015-2025 298

12.4.2 Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), by Segment, 2015-2025 301

12.5 Women's Health Market, Italy, Average Price ($), 2015-2025 304

12.6 Women's Health Market, Italy, Distribution Share by Revenue ($m), 2018 308

12.7 Women's Health Market, Italy, Company Share by Revenue ($m), 2018 309

13 Overview of Key Companies in Italy, In Vitro Diagnostics Market 311

13.1 F. Hoffmann-La Roche Ltd 311

13.1.1 Company Overview 311

13.2 Siemens Healthineers AG 311

13.2.1 Company Overview 311

13.3 Abbott Laboratories 311

13.3.1 Company Overview 311

13.4 Danaher Corp 312

13.4.1 Company Overview 312

13.5 Sysmex Corp 312

13.5.1 Company Overview 312

13.6 Ortho-Clinical Diagnostics Inc 312

13.6.1 Company Overview 312

13.7 Qiagen NV 312

13.7.1 Company Overview 312

13.8 Beckman Coulter Inc 313

13.8.1 Company Overview 313

13.9 Bio-Rad Laboratories Inc 313

13.9.1 Company Overview 313

13.10 Horiba Ltd 313

13.10.1 Company Overview 313

13.11 Hologic Inc 314

13.11.1 Company Overview 314

13.12 bioMerieux SA 314

13.12.1 Company Overview 314

14 In Vitro Diagnostics Market Pipeline Products 315

15 Financial Deals Landscape 319

15.1 Acquisition 319

15.1.1 Lifebrain Acquires Galeno 319

15.1.2 Impact Lab Acquires Toma Advanced Biomedical Assays 320

15.2 Partnerships 321

15.2.1 Fujirebio Europe Enters into Distribution Agreement with Atila Biosystems 321

15.2.2 QuantuMDx and SpeeDx Enter into Agreement with Foundation for Innovative New Diagnostics (FIND) 322

15.2.3 Pillar Biosciences Enters into Co-Marketing Agreement with MGI Tech 323

15.2.4 Dongsung Pharma Enters into Licensing Agreement with Korea Electrotechnology Research Institute 324

15.2.5 Qiagen and DiaSorin Enter into Development Collaboration 325

15.3 Private Equity 326

15.3.1 ArchiMed Acquires Diesse Diagnostica Senese 326

16 Recent Developments 328

16.1 Corporate Communications 328

16.1.1 Sep 12, 2019: Menarini: Elcin Barker Ergun Group CEO 328

16.1.2 Aug 20, 2019: PredictImmune appoints Tim Rea of BGF as non-executive director 328

16.1.3 Jun 19, 2019: Salvatore Butti to become General Manager Italy at STADA Group 329

16.2 Financial Announcements 329

16.2.1 Nov 21, 2019: Bio-Path Holdings announces clearance of Investigational New Drug application for BP1002 329

16.2.2 Jul 17, 2019: Abbott reports second-quarter 2019 results 330

16.2.3 Apr 25, 2019: Biocartis Group Q1 2019 Business Update 332

16.2.4 Apr 24, 2019: Thermo Fisher Scientific announces first quarter 2019 results 335

16.2.5 Mar 21, 2019: IBA reports full year 2018 results 336

16.3 Legal And Regulatory 338

16.3.1 Apr 26, 2019: COPAN Italia announces the filing of a lawsuit against Svenska Laboratorieförsäljningen Aktiebolag, LABFAB, in the Swedish Patent and Market Court, for infringement of European Patent EP 1 608 268 B2 338

16.4 Other Significant Developments 338

16.4.1 May 08, 2019: Pacific Urology to Conduct Overactive Bladder Clinical Feasibility Study 338

16.4.2 Apr 17, 2019: Medibio announces sponsored research agreement with Humanitas University 339

16.4.3 Apr 08, 2019: PHI expands European distributor network 340

16.5 Product News 340

16.5.1 Sep 30, 2019: Blood test may replace biopsy in advanced lung cancer 340

16.5.2 Jun 18, 2019: Menarini Silicon Biosystems introduces use of DEPArray System for challenging flow cytometry applications at CYTO Congress 340

16.5.3 Apr 28, 2019: Single dose of targeted radiotherapy is safe and effective for prostate cancer 341

16.6 Strategy And Business Planning 342

16.6.1 Nov 13, 2019: Thermo Fisher Scientific announces membership of the Pistoia Alliance 342

16.6.2 Jun 07, 2019: Qiagen and DiaSorin to develop test for Lyme disease 342

17 Appendix 344

17.1 Research Methodology 345

17.1.1 Coverage 345

17.1.2 Secondary Research 345

17.1.3 Primary Research 346

17.1.4 Market Modeling and Forecasting 347

17.1.5 Company Share Analysis 348

17.1.6 Distribution Share Analysis 349

17.1.7 Benchmarking 349

17.2 GlobalData Consulting 349

17.3 Contact Us 350

17.4 Disclaimer 350

Table

1.1 List of Tables

Table 1: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, 2015-2025 44

Table 2: In Vitro Diagnostics Market, Italy, Category Contribution by Revenue ($m), 2018 47

Table 3: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2015-2020 49

Table 4: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2021-2025 50

Table 5: In Vitro Diagnostics Market, Italy, Volume (Units), 2015-2025 52

Table 6: In Vitro Diagnostics Market, Italy, Volume (Units), Historic, 2015-2020 54

Table 7: In Vitro Diagnostics Market, Italy, Volume (Units), Forecast, 2021-2025 55

Table 8: In Vitro Diagnostics Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 57

Table 9: Cardiac Disease Market, Italy, Revenue ($m), USD Constant, 2015-2020 59

Table 10: Cardiac Disease Market, Italy, Revenue ($m), USD Constant, 2021-2025 59

Table 11: Cardiac Marker Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 61

Table 12: Cardiac Marker Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 62

Table 13: Cardiac Disease Market, Italy, Volume (Units), 2015-2020 64

Table 14: Cardiac Disease Market, Italy, Volume (Units), 2021-2025 64

Table 15: Cardiac Marker Tests Market, Italy, Volume (Units), 2015-2020 66

Table 16: Cardiac Marker Tests Market, Italy, Volume (Units), 2021-2025 67

Table 17: Cardiac Disease Market, Italy, Average Price ($), 2015-2020 68

Table 18: Cardiac Disease Market, Italy, Average Price ($), 2021-2025 69

Table 19: Cardiac Disease Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2018 70

Table 20: Cardiac Disease Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 72

Table 21: Clinical Chemistry Market, Italy, Revenue ($m), USD Constant, 2015-2020 74

Table 22: Clinical Chemistry Market, Italy, Revenue ($m), USD Constant, 2021-2025 74

Table 23: Substrates Market, Italy, Revenue ($m), USD Constant, 2015-2020 76

Table 24: Substrates Market, Italy, Revenue ($m), USD Constant, 2021-2025 77

Table 25: Clinical Chemistry Market, Italy, Volume (Units), 2015-2020 79

Table 26: Clinical Chemistry Market, Italy, Volume (Units), 2021-2025 79

Table 27: Substrates Market, Italy, Volume (Units), 2015-2020 81

Table 28: Substrates Market, Italy, Volume (Units), 2021-2025 82

Table 29: Clinical Chemistry Market, Italy, Average Price ($), 2015-2020 83

Table 30: Clinical Chemistry Market, Italy, Average Price ($), 2021-2025 84

Table 31: Clinical Chemistry Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2018 85

Table 32: Clinical Chemistry Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 86

Table 33: Hematological Disorders Market, Italy, Segment Contribution (%), 2018 88

Table 34: Hematological Disorders Market, Italy, Revenue ($m), USD Constant, 2015-2020 90

Table 35: Hematological Disorders Market, Italy, Revenue ($m), USD Constant, 2021-2025 90

Table 36: Hematology Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 92

Table 37: Hematology Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 93

Table 38: Hemostasis Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 95

Table 39: Hemostasis Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 96

Table 40: Hematological Disorders Market, Italy, Volume (Units), 2015-2020 98

Table 41: Hematological Disorders Market, Italy, Volume (Units), 2021-2025 98

Table 42: Hematology Tests Market, Italy, Volume (Units), 2015-2020 100

Table 43: Hematology Tests Market, Italy, Volume (Units), 2021-2025 101

Table 44: Hemostasis Tests Market, Italy, Volume (Units), 2015-2020 103

Table 45: Hemostasis Tests Market, Italy, Volume (Units), 2021-2025 104

Table 46: Hematological Disorders Market, Italy, Average Price ($), 2015-2020 105

Table 47: Hematological Disorders Market, Italy, Average Price ($), 2021-2025 107

Table 48: Hematological Disorders Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2018 109

Table 49: Hematological Disorders Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 111

Table 50: Hormonal Disorders Market, Italy, Revenue ($m), USD Constant, 2015-2020 113

Table 51: Hormonal Disorders Market, Italy, Revenue ($m), USD Constant, 2021-2025 113

Table 52: Thyroid Function Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 115

Table 53: Thyroid Function Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 116

Table 54: Hormonal Disorders Market, Italy, Volume (Units), 2015-2020 118

Table 55: Hormonal Disorders Market, Italy, Volume (Units), 2021-2025 118

Table 56: Thyroid Function Tests Market, Italy, Volume (Units), 2015-2020 120

Table 57: Thyroid Function Tests Market, Italy, Volume (Units), 2021-2025 121

Table 58: Hormonal Disorders Market, Italy, Average Price ($), 2015-2020 122

Table 59: Hormonal Disorders Market, Italy, Average Price ($), 2021-2025 123

Table 60: Hormonal Disorders Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2018 124

Table 61: Hormonal Disorders Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 126

Table 62: Infectious Disease Market, Italy, Segment Contribution (%), 2018 129

Table 63: Infectious Disease Market, Italy, Revenue ($m), USD Constant, 2015-2020 131

Table 64: Infectious Disease Market, Italy, Revenue ($m), USD Constant, 2021-2025 132

Table 65: Chlamydia Trachomatis Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 134

Table 66: Chlamydia Trachomatis Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 134

Table 67: Clostridium difficile Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 136

Table 68: Clostridium difficile Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 137

Table 69: Cytomegalovirus (CMV) Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 139

Table 70: Cytomegalovirus (CMV) Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 139

Table 71: Hepatitis Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 141

Table 72: Hepatitis Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 141

Table 73: Human Immunodeficiency Virus (HIV) Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 143

Table 74: Human Immunodeficiency Virus (HIV) Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 144

Table 75: Human Papilloma Virus (HPV) Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 146

Table 76: Human Papilloma Virus (HPV) Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 146

Table 77: Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 148

Table 78: Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 148

Table 79: Mycobacterium Tuberculosis Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 150

Table 80: Mycobacterium Tuberculosis Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 150

Table 81: Neisseria Gonorrhoeae Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 152

Table 82: Neisseria Gonorrhoeae Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 152

Table 83: Treponema pallidum Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 154

Table 84: Treponema pallidum Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 155

Table 85: Infectious Disease Market, Italy, Volume (Units), 2015-2020 157

Table 86: Infectious Disease Market, Italy, Volume (Units), 2021-2025 159

Table 87: Chlamydia Trachomatis Tests Market, Italy, Volume (Units), 2015-2020 162

Table 88: Chlamydia Trachomatis Tests Market, Italy, Volume (Units), 2021-2025 162

Table 89: Clostridium difficile Tests Market, Italy, Volume (Units), 2015-2020 164

Table 90: Clostridium difficile Tests Market, Italy, Volume (Units), 2021-2025 164

Table 91: Cytomegalovirus (CMV) Tests Market, Italy, Volume (Units), 2015-2020 167

Table 92: Cytomegalovirus (CMV) Tests Market, Italy, Volume (Units), 2021-2025 167

Table 93: Hepatitis Tests Market, Italy, Volume (Units), 2015-2020 169

Table 94: Hepatitis Tests Market, Italy, Volume (Units), 2021-2025 169

Table 95: Human Immunodeficiency Virus (HIV) Tests Market, Italy, Volume (Units), 2015-2020 171

Table 96: Human Immunodeficiency Virus (HIV) Tests Market, Italy, Volume (Units), 2021-2025 172

Table 97: Human Papilloma Virus (HPV) Tests Market, Italy, Volume (Units), 2015-2020 174

Table 98: Human Papilloma Virus (HPV) Tests Market, Italy, Volume (Units), 2021-2025 174

Table 99: Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Volume (Units), 2015-2020 176

Table 100: Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Volume (Units), 2021-2025 176

Table 101: Mycobacterium Tuberculosis Tests Market, Italy, Volume (Units), 2015-2020 178

Table 102: Mycobacterium Tuberculosis Tests Market, Italy, Volume (Units), 2021-2025 178

Table 103: Neisseria Gonorrhoeae Tests Market, Italy, Volume (Units), 2015-2020 180

Table 104: Neisseria Gonorrhoeae Tests Market, Italy, Volume (Units), 2021-2025 180

Table 105: Treponema pallidum Tests Market, Italy, Volume (Units), 2015-2020 182

Table 106: Treponema pallidum Tests Market, Italy, Volume (Units), 2021-2025 183

Table 107: Infectious Disease Market, Italy, Average Price ($), 2015-2020 184

Table 108: Infectious Disease Market, Italy, Average Price ($), 2021-2025 187

Table 109: Infectious Disease Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2018 190

Table 110: Infectious Disease Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 192

Table 111: IVD Analyzers and Reagents Market, Italy, Segment Contribution (%), 2018 194

Table 112: IVD Analyzers and Reagents Market, Italy, Revenue ($m), USD Constant, 2015-2020 196

Table 113: IVD Analyzers and Reagents Market, Italy, Revenue ($m), USD Constant, 2021-2025 197

Table 114: Clinical Chemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2015-2020 199

Table 115: Clinical Chemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2021-2025 199

Table 116: Hematology Analyzers Market, Italy, Revenue ($m), USD Constant, 2015-2020 201

Table 117: Hematology Analyzers Market, Italy, Revenue ($m), USD Constant, 2021-2025 202

Table 118: Immunochemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2015-2020 204

Table 119: Immunochemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2021-2025 205

Table 120: Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), USD Constant, 2015-2020 207

Table 121: Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), USD Constant, 2021-2025 208

Table 122: IVD Analyzers and Reagents Market, Italy, Volume (Units), 2015-2020 210

Table 123: IVD Analyzers and Reagents Market, Italy, Volume (Units), 2021-2025 211

Table 124: Clinical Chemistry Analyzers Market, Italy, Volume (Units), 2015-2020 213

Table 125: Clinical Chemistry Analyzers Market, Italy, Volume (Units), 2021-2025 213

Table 126: Hematology Analyzers Market, Italy, Volume (Units), 2015-2020 215

Table 127: Hematology Analyzers Market, Italy, Volume (Units), 2021-2025 216

Table 128: Immunochemistry Analyzers Market, Italy, Volume (Units), 2015-2020 218

Table 129: Immunochemistry Analyzers Market, Italy, Volume (Units), 2021-2025 219

Table 130: Polymerase Chain Reaction (PCR) Systems Market, Italy, Volume (Units), 2015-2020 221

Table 131: Polymerase Chain Reaction (PCR) Systems Market, Italy, Volume (Units), 2021-2025 222

Table 132: IVD Analyzers and Reagents Market, Italy, Average Price ($), 2015-2020 223

Table 133: IVD Analyzers and Reagents Market, Italy, Average Price ($), 2021-2025 225

Table 134: IVD Analyzers and Reagents Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2018 227

Table 135: IVD Analyzers and Reagents Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 229

Table 136: Metabolic Disorder Market, Italy, Revenue ($m), USD Constant, 2015-2020 231

Table 137: Metabolic Disorder Market, Italy, Revenue ($m), USD Constant, 2021-2025 231

Table 138: Diabetes Assays Market, Italy, Revenue ($m), USD Constant, 2015-2020 233

Table 139: Diabetes Assays Market, Italy, Revenue ($m), USD Constant, 2021-2025 234

Table 140: Metabolic Disorder Market, Italy, Volume (Units), 2015-2020 236

Table 141: Metabolic Disorder Market, Italy, Volume (Units), 2021-2025 236

Table 142: Diabetes Assays Market, Italy, Volume (Units), 2015-2020 238

Table 143: Diabetes Assays Market, Italy, Volume (Units), 2021-2025 239

Table 144: Metabolic Disorder Market, Italy, Average Price ($), 2015-2020 240

Table 145: Metabolic Disorder Market, Italy, Average Price ($), 2021-2025 241

Table 146: Metabolic Disorder Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2018 242

Table 147: Metabolic Disorder Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 244

Table 148: Oncology Market, Italy, Segment Contribution (%), 2018 247

Table 149: Oncology Market, Italy, Revenue ($m), USD Constant, 2015-2020 249

Table 150: Oncology Market, Italy, Revenue ($m), USD Constant, 2021-2025 250

Table 151: ALK Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 252

Table 152: ALK Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 252

Table 153: BRCA Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 254

Table 154: BRCA Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 254

Table 155: Colorectal Cancer Screening Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 256

Table 156: Colorectal Cancer Screening Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 256

Table 157: EGFR Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 258

Table 158: EGFR Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 259

Table 159: HER2 Amplification Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 261

Table 160: HER2 Amplification Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 261

Table 161: KRAS Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 263

Table 162: KRAS Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 263

Table 163: Oncology Market, Italy, Volume (Units), 2015-2020 265

Table 164: Oncology Market, Italy, Volume (Units), 2021-2025 266

Table 165: ALK Tests Market, Italy, Volume (Units), 2015-2020 268

Table 166: ALK Tests Market, Italy, Volume (Units), 2021-2025 268

Table 167: BRCA Tests Market, Italy, Volume (Units), 2015-2020 270

Table 168: BRCA Tests Market, Italy, Volume (Units), 2021-2025 270

Table 169: Colorectal Cancer Screening Tests Market, Italy, Volume (Units), 2015-2020 272

Table 170: Colorectal Cancer Screening Tests Market, Italy, Volume (Units), 2021-2025 272

Table 171: EGFR Tests Market, Italy, Volume (Units), 2015-2020 274

Table 172: EGFR Tests Market, Italy, Volume (Units), 2021-2025 275

Table 173: HER2 Amplification Tests Market, Italy, Volume (Units), 2015-2020 277

Table 174: HER2 Amplification Tests Market, Italy, Volume (Units), 2021-2025 277

Table 175: KRAS Tests Market, Italy, Volume (Units), 2015-2020 279

Table 176: KRAS Tests Market, Italy, Volume (Units), 2021-2025 279

Table 177: Oncology Market, Italy, Average Price ($), 2015-2020 280

Table 178: Oncology Market, Italy, Average Price ($), 2021-2025 282

Table 179: Oncology Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2018 284

Table 180: Oncology Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 286

Table 181: Women's Health Market, Italy, Segment Contribution (%), 2018 288

Table 182: Women's Health Market, Italy, Revenue ($m), USD Constant, 2015-2020 290

Table 183: Women's Health Market, Italy, Revenue ($m), USD Constant, 2021-2025 290

Table 184: Prenatal Screening Market, Italy, Revenue ($m), USD Constant, 2015-2020 292

Table 185: Prenatal Screening Market, Italy, Revenue ($m), USD Constant, 2021-2025 293

Table 186: Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), USD Constant, 2015-2020 295

Table 187: Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), USD Constant, 2021-2025 296

Table 188: Women's Health Market, Italy, Volume (Units), 2015-2020 298

Table 189: Women's Health Market, Italy, Volume (Units), 2021-2025 298

Table 190: Prenatal Screening Market, Italy, Volume (Units), 2015-2020 300

Table 191: Prenatal Screening Market, Italy, Volume (Units), 2021-2025 301

Table 192: Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), 2015-2020 303

Table 193: Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), 2021-2025 304

Table 194: Women's Health Market, Italy, Average Price ($), 2015-2020 305

Table 195: Women's Health Market, Italy, Average Price ($), 2021-2025 307

Table 196: Women's Health Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2018 309

Table 197: Women's Health Market, Italy, Company Share by Revenue ($m), USD Constant, 2018 311

Table 198: In Vitro Diagnostics Market Pipeline Products 316

Table 199: Lifebrain Acquires Galeno 320

Table 200: Impact Lab Acquires Toma Advanced Biomedical Assays 321

Table 201: Fujirebio Europe Enters into Distribution Agreement with Atila Biosystems 322

Table 202: QuantuMDx and SpeeDx Enter into Agreement with Foundation for Innovative New Diagnostics (FIND) 323

Table 203: Pillar Biosciences Enters into Co-Marketing Agreement with MGI Tech 324

Table 204: Dongsung Pharma Enters into Licensing Agreement with Korea Electrotechnology Research Institute 325

Table 205: Qiagen and DiaSorin Enter into Development Collaboration 326

Table 206: ArchiMed Acquires Diesse Diagnostica Senese 327

Table 207: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 348

Figures

1.2 List of Figures

Figure 1: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, 2015-2025 43

Figure 2: In Vitro Diagnostics Market, Italy, Revenue Mix ($m), 2018 45

Figure 3: In Vitro Diagnostics Market, Italy, Category Contribution (%), 2018 46

Figure 4: In Vitro Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2015-2025 48

Figure 5: In Vitro Diagnostics Market, Italy, Volume (Units), 2015-2025 51

Figure 6: In Vitro Diagnostics Market, Italy, Volume (Units), Historic, 2015-2025 53

Figure 7: In Vitro Diagnostics Market, Italy, Company Share (%) 2018 56

Figure 8: Cardiac Disease Market, Italy, Revenue ($m), USD Constant, 2015-2025 58

Figure 9: Cardiac Marker Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 60

Figure 10: Cardiac Disease Market, Italy, Volume (Units), 2015-2025 63

Figure 11: Cardiac Marker Tests Market, Italy, Volume (Units), 2015-2025 65

Figure 12: Cardiac Disease Market, Italy, Company Share (%) 2018 71

Figure 13: Clinical Chemistry Market, Italy, Revenue ($m), USD Constant, 2015-2025 73

Figure 14: Substrates Market, Italy, Revenue ($m), USD Constant, 2015-2025 75

Figure 15: Clinical Chemistry Market, Italy, Volume (Units), 2015-2025 78

Figure 16: Substrates Market, Italy, Volume (Units), 2015-2025 80

Figure 17: Clinical Chemistry Market, Italy, Company Share (%) 2018 86

Figure 18: Hematological Disorders Market, Italy, Revenue Mix ($m), 2018 87

Figure 19: Hematological Disorders Market, Italy, Segment Contribution (%), 2018 88

Figure 20: Hematological Disorders Market, Italy, Revenue ($m), USD Constant, 2015-2025 89

Figure 21: Hematology Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 91

Figure 22: Hemostasis Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 94

Figure 23: Hematological Disorders Market, Italy, Volume (Units), 2015-2025 97

Figure 24: Hematology Tests Market, Italy, Volume (Units), 2015-2025 99

Figure 25: Hemostasis Tests Market, Italy, Volume (Units), 2015-2025 102

Figure 26: Hematological Disorders Market, Italy, Company Share (%) 2018 110

Figure 27: Hormonal Disorders Market, Italy, Revenue ($m), USD Constant, 2015-2025 112

Figure 28: Thyroid Function Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 114

Figure 29: Hormonal Disorders Market, Italy, Volume (Units), 2015-2025 117

Figure 30: Thyroid Function Tests Market, Italy, Volume (Units), 2015-2025 119

Figure 31: Hormonal Disorders Market, Italy, Company Share (%) 2018 125

Figure 32: Infectious Disease Market, Italy, Revenue Mix ($m), 2018 127

Figure 33: Infectious Disease Market, Italy, Segment Contribution (%), 2018 128

Figure 34: Infectious Disease Market, Italy, Revenue ($m), USD Constant, 2015-2025 130

Figure 35: Chlamydia Trachomatis Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 133

Figure 36: Clostridium difficile Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 135

Figure 37: Cytomegalovirus (CMV) Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 138

Figure 38: Hepatitis Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 140

Figure 39: Human Immunodeficiency Virus (HIV) Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 142

Figure 40: Human Papilloma Virus (HPV) Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 145

Figure 41: Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 147

Figure 42: Mycobacterium Tuberculosis Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 149

Figure 43: Neisseria Gonorrhoeae Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 151

Figure 44: Treponema pallidum Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 153

Figure 45: Infectious Disease Market, Italy, Volume (Units), 2015-2025 156

Figure 46: Chlamydia Trachomatis Tests Market, Italy, Volume (Units), 2015-2025 161

Figure 47: Clostridium difficile Tests Market, Italy, Volume (Units), 2015-2025 163

Figure 48: Cytomegalovirus (CMV) Tests Market, Italy, Volume (Units), 2015-2025 166

Figure 49: Hepatitis Tests Market, Italy, Volume (Units), 2015-2025 168

Figure 50: Human Immunodeficiency Virus (HIV) Tests Market, Italy, Volume (Units), 2015-2025 170

Figure 51: Human Papilloma Virus (HPV) Tests Market, Italy, Volume (Units), 2015-2025 173

Figure 52: Human T-Lymphotropic Virus (HTLV) Tests Market, Italy, Volume (Units), 2015-2025 175

Figure 53: Mycobacterium Tuberculosis Tests Market, Italy, Volume (Units), 2015-2025 177

Figure 54: Neisseria Gonorrhoeae Tests Market, Italy, Volume (Units), 2015-2025 179

Figure 55: Treponema pallidum Tests Market, Italy, Volume (Units), 2015-2025 181

Figure 56: Infectious Disease Market, Italy, Company Share (%) 2018 191

Figure 57: IVD Analyzers and Reagents Market, Italy, Revenue Mix ($m), 2018 193

Figure 58: IVD Analyzers and Reagents Market, Italy, Segment Contribution (%), 2018 194

Figure 59: IVD Analyzers and Reagents Market, Italy, Revenue ($m), USD Constant, 2015-2025 195

Figure 60: Clinical Chemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2015-2025 198

Figure 61: Hematology Analyzers Market, Italy, Revenue ($m), USD Constant, 2015-2025 200

Figure 62: Immunochemistry Analyzers Market, Italy, Revenue ($m), USD Constant, 2015-2025 203

Figure 63: Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), USD Constant, 2015-2025 206

Figure 64: IVD Analyzers and Reagents Market, Italy, Volume (Units), 2015-2025 209

Figure 65: Clinical Chemistry Analyzers Market, Italy, Volume (Units), 2015-2025 212

Figure 66: Hematology Analyzers Market, Italy, Volume (Units), 2015-2025 214

Figure 67: Immunochemistry Analyzers Market, Italy, Volume (Units), 2015-2025 217

Figure 68: Polymerase Chain Reaction (PCR) Systems Market, Italy, Volume (Units), 2015-2025 220

Figure 69: IVD Analyzers and Reagents Market, Italy, Company Share (%) 2018 228

Figure 70: Metabolic Disorder Market, Italy, Revenue ($m), USD Constant, 2015-2025 230

Figure 71: Diabetes Assays Market, Italy, Revenue ($m), USD Constant, 2015-2025 232

Figure 72: Metabolic Disorder Market, Italy, Volume (Units), 2015-2025 235

Figure 73: Diabetes Assays Market, Italy, Volume (Units), 2015-2025 237

Figure 74: Metabolic Disorder Market, Italy, Company Share (%) 2018 243

Figure 75: Oncology Market, Italy, Revenue Mix ($m), 2018 245

Figure 76: Oncology Market, Italy, Segment Contribution (%), 2018 246

Figure 77: Oncology Market, Italy, Revenue ($m), USD Constant, 2015-2025 248

Figure 78: ALK Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 251

Figure 79: BRCA Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 253

Figure 80: Colorectal Cancer Screening Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 255

Figure 81: EGFR Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 257

Figure 82: HER2 Amplification Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 260

Figure 83: KRAS Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 262

Figure 84: Oncology Market, Italy, Volume (Units), 2015-2025 264

Figure 85: ALK Tests Market, Italy, Volume (Units), 2015-2025 267

Figure 86: BRCA Tests Market, Italy, Volume (Units), 2015-2025 269

Figure 87: Colorectal Cancer Screening Tests Market, Italy, Volume (Units), 2015-2025 271

Figure 88: EGFR Tests Market, Italy, Volume (Units), 2015-2025 273

Figure 89: HER2 Amplification Tests Market, Italy, Volume (Units), 2015-2025 276

Figure 90: KRAS Tests Market, Italy, Volume (Units), 2015-2025 278

Figure 91: Oncology Market, Italy, Company Share (%) 2018 285

Figure 92: Women's Health Market, Italy, Revenue Mix ($m), 2018 287

Figure 93: Women's Health Market, Italy, Segment Contribution (%), 2018 288

Figure 94: Women's Health Market, Italy, Revenue ($m), USD Constant, 2015-2025 289

Figure 95: Prenatal Screening Market, Italy, Revenue ($m), USD Constant, 2015-2025 291

Figure 96: Reproductive Hormones and Proteins Tests Market, Italy, Revenue ($m), USD Constant, 2015-2025 294

Figure 97: Women's Health Market, Italy, Volume (Units), 2015-2025 297

Figure 98: Prenatal Screening Market, Italy, Volume (Units), 2015-2025 299

Figure 99: Reproductive Hormones and Proteins Tests Market, Italy, Volume (Units), 2015-2025 302

Figure 100: Women's Health Market, Italy, Company Share (%) 2018 310

Frequently asked questions

Italy In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. standard reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Italy In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. in real time.

  • Access a live Italy In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others. dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.